B Chauffert, B Bonnotte, G Chvetzoff, M Flesch. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Adenocarcinoma, Clear Cell/drug therapyAdenocarcinoma, Clear Cell/pathologyAdenocarcinoma, Clear Cell/secondaryAntidotes/administration & dosageAntimetabolites, Antineoplastic/administration & dosageAntineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useFemaleFluorouracil/administration & dosageHumansKidney Neoplasms/pathologyLeucovorin/administration & dosageLiver Neoplasms/drug therapyLiver Neoplasms/secondaryMiddle AgedOrganoplatinum Compounds/administration & dosageOxaliplatinPleural Neoplasms/drug therapyPleural Neoplasms/secondary
Substances： See more » AntidotesAntimetabolites, AntineoplasticAntineoplastic AgentsOrganoplatinum CompoundsOxaliplatinLeucovorinFluorouracil
Year: 1998 PMID： 9767871
Source DB: PubMed Journal: Presse Med ISSN： 0755-4982 Impact factor: 1.228